Abstract
INTRODUCTION Research into quantitative neuroimaging biomarkers of dementia risk rarely uses data representative of everyday clinic practice.
METHODS We analysed T1-weighted MRI scans from memory clinic patients (n=1140; 60.2% female and mean [SD] age of 70.0 [10.8] years) to derive ‘brain-age’, an index of age-related brain health. We determined which patients went on to develop dementia (n=476) via linkage to electronic health records.
RESULTS Cox regression indicated a 3% increased risk of dementia per brain-PAD year (brain-PAD = brain-age minus chronological age), HR(95% CI)=1.03(1.02, 1.04), p<0.001, adjusted for age, age2, sex, MMSE and normalised brain volume. Brain-PAD remained significant even with a minimum time-to-diagnosis of 3 years (HR=1.06) and with MMSE score ≥ 27 (HR=1.03).
DISCUSSION Memory clinic patients with older-appearing brains are more likely to receive a subsequent dementia diagnosis. These results from a ‘real-world’ dataset suggest quantitative neuroimaging biomarkers like brain-age could be readily used in the clinic.
SYSTEMATIC REVIEW Multiple previous studies were identified that have modelled dementia risk using quantitative neuroimaging, however, screening of participants based on comorbidities and contraindications alongside sociodemographic and healthcare sampling biases, limits the generalisation of these studies to real-world clinical settings. To facilitate better translation from research to the clinic, datasets that are more representative of dementia patient groups are warranted.
INTERPRETATION Brain-age is an index of ‘biological’ age based on a quantitative analysis of T1-weighted MRI scans. Memory clinic patients with biologically older-appearing brains are more likely to receive a subsequent dementia diagnosis, independent of medical history, age, sex, MMSE score and normalised brain volumes. These findings suggest that brain-age has potential to be used early-on in memory clinics as a biomarker to aid detection of patients at high-risk of developing dementia.
FUTURE DIRECTIONS Does the addition of T2-weighted MRI scan information and/or localised brain-age values improve dementia prediction?
Competing Interest Statement
Authors report no conflicts of interest. Potential conflict of interest: JHC is a scientific advisor to and shareholder in Brain Key, a medical image analysis company.
Funding Statement
The study was funded by a Wellcome Trust Seed Award in Science (213996/Z/18/Z). CM receives salary support from the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. CJS receives salary support from Medical Research Council, the Wellcome Trust and the Chronic Disease Research Foundation. This paper represents independent research partly funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Oxford REC C reference 18/SC/0372 & NIHR Maudsley Biomedical Research Centre: CRIS reference 19-008
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Patient data not available.
Acronyms
- (ACE)
- Addenbrookes’ Cognitive Examination
- (AD)
- Alzheimer’s disease
- (brain-PAD)
- Brain Predicted Age Difference
- (BRC)
- Maudsley NIHR Biomedical Research Centre
- (CRIS)
- Clinical Record Interactive Search
- (EHRs)
- Electronic Health Records
- (HES)
- Hospital Episode Statistics
- (MCI)
- Mild Cognitive Impairment
- (MMSE)
- Mini-Mental State Examination
- (MRI)
- Magnetic Resonance Imaging
- (NLP)
- Natural Language Processing
- (ONS)
- Office of National Statistics
- (PET)
- Positron Emission Tomography
- (QC)
- Quality Control
- (SLaM NHS)
- South London and the Maudsley National Health Service Foundation Trust
